These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


488 related items for PubMed ID: 4544796

  • 1. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M.
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract] [Full Text] [Related]

  • 2. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC, Senik A, Gomard E, Plata F, Levy JP.
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract] [Full Text] [Related]

  • 3. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F, Gomard E, Leclerc JC, Levy JP.
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract] [Full Text] [Related]

  • 4. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
    Freedman LR, Cerottini JC, Brunner KT.
    J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
    [No Abstract] [Full Text] [Related]

  • 5. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells.
    Dennert G, Lennox ES.
    J Immunol; 1974 Nov; 113(5):1553-61. PubMed ID: 4213868
    [No Abstract] [Full Text] [Related]

  • 6. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF, Dennert G, Lennox ES.
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B.
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract] [Full Text] [Related]

  • 8. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF, Ceglowski WS, Friedman H.
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract] [Full Text] [Related]

  • 9. Cell interactions in adoptive immune rejection of a syngeneic tumor.
    Howell SB, Dean JH, Esber EC, Llaw LW.
    Int J Cancer; 1974 Nov 15; 14(5):662-74. PubMed ID: 4376531
    [No Abstract] [Full Text] [Related]

  • 10. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT, Röllinghoff M, Warner NL.
    Eur J Immunol; 1973 Apr 15; 3(4):218-24. PubMed ID: 4541468
    [No Abstract] [Full Text] [Related]

  • 11. Phagocytic cells as effectors in a cell-mediated immunity system.
    Dennert G, Lennox ES.
    J Immunol; 1973 Dec 15; 111(6):1844-54. PubMed ID: 4543031
    [No Abstract] [Full Text] [Related]

  • 12. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.
    Treves AJ, Carnaud C, Trainin N, Feldman M, Cohen IR.
    Eur J Immunol; 1974 Nov 15; 4(11):722-7. PubMed ID: 4547711
    [No Abstract] [Full Text] [Related]

  • 13. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
    Egusa K.
    Acta Med Okayama; 1973 Aug 15; 27(3):107-23. PubMed ID: 4357059
    [No Abstract] [Full Text] [Related]

  • 14. Primary and secondary immune response induced in vitro against syngeneic murine plasma cell tumors.
    Röllinghoff M, Wagner H.
    Boll Ist Sieroter Milan; 1974 Aug 15; 53(1):suppl:304. PubMed ID: 4546887
    [No Abstract] [Full Text] [Related]

  • 15. Mechanism of allograft rejection in New Zealand mice. II. Role of a serum factor.
    Gelfand MC, Parker LM, Steinberg AD.
    J Immunol; 1974 Jul 15; 113(1):1-8. PubMed ID: 4598887
    [No Abstract] [Full Text] [Related]

  • 16. Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.
    Eggers AE, Wunderlich JR.
    J Immunol; 1975 May 15; 114(5):1554-6. PubMed ID: 123545
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN, Florentz K, Güttler F.
    Transplant Proc; 1974 Mar 15; 6(1):95-9. PubMed ID: 4817057
    [No Abstract] [Full Text] [Related]

  • 18. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Einstein AB, Fass L, Fefer A.
    Cancer Res; 1975 Mar 15; 35(3):492-6. PubMed ID: 1078784
    [Abstract] [Full Text] [Related]

  • 19. Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge.
    Holden HT, Kirchner H, Herberman RB.
    J Immunol; 1975 Aug 15; 115(2):327-31. PubMed ID: 168259
    [Abstract] [Full Text] [Related]

  • 20. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT, Wagner H, Harris AW.
    J Immunol; 1972 May 15; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.